Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

Why is Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 2.62% and Operating profit at -211.49% over the last 5 years

The company has declared negative results for the last 8 consecutive quarters

NET SALES(HY) At CNY 832.48 MM has Grown at -38.54%
OPERATING CASH FLOW(Y) Lowest at CNY 298.68 MM
PRE-TAX PROFIT(Q) At CNY -96.56 MM has Fallen at -145.06%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -38.22%, its profits have fallen by -57.1%
At the current price, the company has a high dividend yield of 0

Below par performance in long term as well as near term

Along with generating -38.22% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

-38.22%

-1.04

29.04%

China Shanghai Composite

14.77%

1.01

14.58%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

2.62%

EBIT Growth (5y)

-211.49%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.29

Sales to Capital Employed (avg)

0.36

Tax Ratio

35.52%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

37.98%

ROE (avg)

24.39%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

5.86

EV to EBIT

-112.89

EV to EBITDA

-284.30

EV to Capital Employed

8.95

EV to Sales

39.01

PEG Ratio

Dividend Yield

ROCE (Latest)

-7.93%

ROE (Latest)

-2.85%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bullish

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-36What is not working for the Company

NET SALES(HY)

At CNY 832.48 MM has Grown at -38.54%

OPERATING CASH FLOW(Y)

Lowest at CNY 298.68 MM

PRE-TAX PROFIT(Q)

At CNY -96.56 MM has Fallen at -145.06%

NET PROFIT(Q)

At CNY -100.03 MM has Fallen at -251.64%

ROCE(HY)

Lowest at -2.42%

INTEREST(Q)

At CNY 11.58 MM has Grown at 471.48%

RAW MATERIAL COST(Y)

Grown by 35.85% (YoY

DEBT-EQUITY RATIO (HY)

Highest at -38.34 %

Here's what is not working for Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

Net Sales

At CNY 832.48 MM has Grown at -38.54%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (CNY MM)

Pre-Tax Profit

At CNY -96.56 MM has Fallen at -145.06%

over average net sales of the previous four periods of CNY -39.4 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY -100.03 MM has Fallen at -251.64%

over average net sales of the previous four periods of CNY -28.45 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow

Lowest at CNY 298.68 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest

At CNY 11.58 MM has Grown at 471.48%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest

Highest at CNY 11.58 MM

in the last five periods and Increased by 471.48% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debt-Equity Ratio

Highest at -38.34 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost

Grown by 35.85% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales